Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin
Open Access
- 1 July 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of Lipid Research
- Vol. 38 (7) , 1496-1500
- https://doi.org/10.1016/s0022-2275(20)37432-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemiaAtherosclerosis, 1996
- Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart diseaseCurrent Opinion in Lipidology, 1995
- Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal modelsAtherosclerosis, 1995
- Angiographic trials of lipid-lowering therapy: end of an era?Heart, 1995
- Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase InhibitorArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Correspondence between plasma mevalonic acid levels and deuterium uptake in measuring human cholesterol synthesisEuropean Journal of Clinical Investigation, 1992
- Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitorsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects. A double-blind comparative study.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Plasma mevalonate as a measure of cholesterol synthesis in man.Journal of Clinical Investigation, 1984